GLUD1: Glutamate Dehydrogenase 1

Key enzyme in glutamate metabolism and ammonia detoxification

Gene Information Card

Symbol GLUD1
Full Name Glutamate Dehydrogenase 1
Gene Type Protein coding
Chromosomal Location 10q23.2
NCBI Gene ID 2746 ncbi.nlm.nih.gov/gene/2746
Ensembl ID ENSG00000148672
UniProt ID P00367
OMIM ID 138130
HGNC ID 4335
Aliases GDH, GDH1, GLUD

Description

GLUD1 encodes glutamate dehydrogenase 1 (GDH), a mitochondrial matrix enzyme that catalyzes the reversible oxidative deamination of glutamate to alpha-ketoglutarate and ammonia, using NAD+ or NADP+ as cofactors. This enzyme plays a critical role in amino acid metabolism, ammonia detoxification, and insulin secretion regulation. Mutations in GLUD1 cause hyperinsulinism-hyperammonemia syndrome, characterized by hypoglycemia and elevated ammonia levels.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hyperinsulinism-hyperammonemia syndrome Gain-of-function mutations in GLUD1 reduce sensitivity to allosteric inhibition by GTP, leading to increased GDH activity, excessive insulin secretion, and elevated ammonia production. ClinVar, OMIM #138130
Congenital hyperinsulinism GLUD1 mutations cause a dominant form of hyperinsulinism with leucine sensitivity, due to dysregulated glutamate metabolism in pancreatic beta-cells. ClinVar, OMIM #606762
Epileptic encephalopathy Rare de novo missense variants in GLUD1 have been associated with early-onset seizures and developmental delay, likely due to altered neurotransmitter cycling. ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.3 High
Pancreas 8.7 Medium
Brain 6.5 Medium
Kidney 9.1 Medium
Heart 4.2 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.5 Hepatocyte model
SH-SY5Y 7.8 Neuroblastoma line
HEK293 5.3 Embryonic kidney
MIN6 11.2 Pancreatic beta-cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1493C>T (p.Ser498Leu) Missense ~40% of HIHA cases Gain-of-function; reduces GTP inhibition
c.965G>A (p.Arg322His) Missense ~15% of HIHA cases Gain-of-function; alters allosteric regulation
c.1519G>A (p.Gly507Arg) Missense Rare Gain-of-function; associated with severe hypoglycemia
c.820C>T (p.Arg274Cys) Missense Rare Gain-of-function; leucine-sensitive hyperinsulinism
Mutation functional classification

Loss of Function (LOF)

No confirmed loss-of-function mutations reported in human disease; homozygous knockout is lethal in mice.

Gain of Function (GOF)

Most GLUD1 mutations are gain-of-function, reducing sensitivity to allosteric inhibition by GTP and ADP, leading to increased enzyme activity.

Dominant Negative (DN)

Not described for GLUD1; all pathogenic mutations are dominant gain-of-function.

Pathways

KEGG: hsa00250 - Alanine
aspartate and glutamate metabolism
KEGG: hsa00330 - Arginine and proline metabolism
Reactome: R-HSA-210500 - Glutamate and glutamine metabolism

Protein Summary

Glutamate dehydrogenase 1 (GDH) is a 558-amino acid mitochondrial enzyme encoded by GLUD1. It forms homohexamers and catalyzes the reversible conversion of glutamate to alpha-ketoglutarate and ammonia. GDH is allosterically regulated by GTP (inhibitor) and ADP (activator). The enzyme is highly expressed in liver, pancreas, kidney, and brain, where it integrates carbon and nitrogen metabolism. Gain-of-function mutations cause hyperinsulinism-hyperammonemia syndrome.

Related Products

Product name Cat.No. Species Gene ID
GLUD1 Knockout HEK293 Cell Line EDJ-KQ50303 Human 2746 Details Get a Quote
GLUD1 Knockout HeLa Cell Line EDJ-KQ53359 Human 2746 Details Get a Quote
GLUD1 Knockout A-549 Cell Line EDJ-KQ61837 Human 2746 Details Get a Quote
GLUD1 Knockout HCT 116 Cell Line EDJ-KQ70322 Human 2746 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: